BMS 180742
BMS 180742 is a thrombin exosite inhibitor. BMS 180742 does not inhibit arterial thrombosis[1].
Product Specifications
CAS Number
138828-04-3
UNSPSC
12352209
Target
Thrombin
Type
Peptides
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/bms-180742.html
Smiles
O=C([C@H]1N(CCC1)C([C@H](CCC(O)=O)NC([C@@H](NC(CCC(O)=O)=O)CC2=CC=CC=C2)=O)=O)N[C@@H]([C@@H](C)CC)C(N3[C@@H](CCC3)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(O)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CCC(N)=O)=O)CC4CCCCC4)=O)CC5=CC=C(C=C5)O)=O)=O)=O)=O
Molecular Formula
C67H93N11O22
Molecular Weight
1404.52
References & Citations
[1]Schumacher WA, et al. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding. J Pharmacol Exp Ther. 1993 Dec;267 (3) :1237-42.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-61217R-APC-Cy5.5 100 µL
ATG7 Recombinant Antibody, APC-Cy5.5 Conjugated
Sign In for Pricing
View Details 474725 100 µL
ADAM19 (Disintegrin and Metalloproteinase Domain-Containing Protein 19, ADAM Metallopeptidase Domain 19)
Sign In for Pricing
View Details